ID

42548

Description

Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled out whenever/if Pharmacogenetic Research consent has to be given/withdrawn or blood samples have to be collected during study.

Link

https://clinicaltrials.gov/ct2/show/NCT00811733

Keywords

  1. 8/25/21 8/25/21 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 25, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733

Pharmacogenetic Research

Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
date of visit/assessment
Description

date of visit/assessment

Data type

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
subject number
Description

subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Pharmacogenetic (PGx) Research Consent/Blood Sample Collection
Description

Pharmacogenetic (PGx) Research Consent/Blood Sample Collection

Alias
UMLS CUI-1
C2347500
UMLS CUI-2
C0021430
UMLS CUI-3
C0005834
Has informed consent been obtained for PGx research?
Description

Informed consent for PGx research

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C2347500
If yes, record Date informed consent obtained for PGx research
Description

Informed consent for PGx research, Date

Data type

date

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C2347500
UMLS CUI [1,3]
C0011008
Has blood sample been collected for PGx research?
Description

Blood sample for PGx research

Data type

boolean

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C2347500
If yes, record Date sample taken
Description

Blood sample for PGx research, Date sample taken

Data type

date

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C2347500
UMLS CUI [1,3]
C1302413
If no, check reason
Description

No informed consent for PGx research, reason

Data type

text

Alias
UMLS CUI [1,1]
C1298908
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C2347500
UMLS CUI [1,4]
C0566251
If other, specify
Description

No informed consent for PGx research, other reason

Data type

text

Alias
UMLS CUI [1,1]
C1298908
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C2347500
UMLS CUI [1,4]
C0566251
UMLS CUI [1,5]
C0205394
Sample Type
Description

[hidden]

Data type

text

Alias
UMLS CUI [1]
C2347029
Withdrawal of Consent for PGx (DNA) / Blood Sample Destruction
Description

Withdrawal of Consent for PGx (DNA) / Blood Sample Destruction

Alias
UMLS CUI-1
C1707492
UMLS CUI-2
C2347500
UMLS CUI-3
C1948029
UMLS CUI-4
C0178913
Has subject withdrawn consent for PGx research?
Description

Consent withdrawn for PGx research

Data type

boolean

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2347500
If yes, date informed consent withdrawn
Description

Consent withdrawn for PGx research, Date

Data type

partialDate

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2347500
UMLS CUI [1,3]
C0011008
Has a request been made for (insert sample type) sample destruction?
Description

Please replace 'blood' with the appropriate sample type as specified in the protocol.

Data type

boolean

Alias
UMLS CUI [1,1]
C1272683
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C0178913
UMLS CUI [1,4]
C2347500
If yes, check reason
Description

Please replace 'blood' with the appropriate sample type as specified in the protocol. Screen failure is an optional choice.

Data type

text

Alias
UMLS CUI [1,1]
C1272683
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C0178913
UMLS CUI [1,4]
C0566251
UMLS CUI [1,5]
C2347500
If other, specify
Description

Please replace 'blood' with the appropriate sample type as specified in the protocol.

Data type

text

Alias
UMLS CUI [1,1]
C1272683
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C0178913
UMLS CUI [1,4]
C0566251
UMLS CUI [1,5]
C0205394
UMLS CUI [1,6]
C2347500
Sample type
Description

[hidden]

Data type

text

Alias
UMLS CUI [1]
C2347029

Similar models

Pharmacogenetic Research

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
date of visit/assessment
Item
date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
subject ID
Item
subject number
text
C2348585 (UMLS CUI [1])
Item Group
Pharmacogenetic (PGx) Research Consent/Blood Sample Collection
C2347500 (UMLS CUI-1)
C0021430 (UMLS CUI-2)
C0005834 (UMLS CUI-3)
Informed consent for PGx research
Item
Has informed consent been obtained for PGx research?
boolean
C0021430 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
Informed consent for PGx research, Date
Item
If yes, record Date informed consent obtained for PGx research
date
C0021430 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Blood sample for PGx research
Item
Has blood sample been collected for PGx research?
boolean
C0005834 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
Blood sample for PGx research, Date sample taken
Item
If yes, record Date sample taken
date
C0005834 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
C1302413 (UMLS CUI [1,3])
Item
If no, check reason
text
C1298908 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other, specify (Z)
No informed consent for PGx research, other reason
Item
If other, specify
text
C1298908 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
Sample Type
Item
Sample Type
text
C2347029 (UMLS CUI [1])
Item Group
Withdrawal of Consent for PGx (DNA) / Blood Sample Destruction
C1707492 (UMLS CUI-1)
C2347500 (UMLS CUI-2)
C1948029 (UMLS CUI-3)
C0178913 (UMLS CUI-4)
Consent withdrawn for PGx research
Item
Has subject withdrawn consent for PGx research?
boolean
C1707492 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
Consent withdrawn for PGx research, Date
Item
If yes, date informed consent withdrawn
partialDate
C1707492 (UMLS CUI [1,1])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Request for sample destruction
Item
Has a request been made for (insert sample type) sample destruction?
boolean
C1272683 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,4])
Item
If yes, check reason
text
C1272683 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C2347500 (UMLS CUI [1,5])
Code List
If yes, check reason
CL Item
Subject withdrew consent for PGx (3)
CL Item
Other (Z)
CL Item
Screen failure (1)
Request for sample destruction, other reason
Item
If other, specify
text
C1272683 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
C2347500 (UMLS CUI [1,6])
Sample type
Item
Sample type
text
C2347029 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial